Completed PHASE1/PHASE2 INTERVENTIONAL NCT01264952

Treatment of Liver Metastases With Electrochemotherapy (ECTJ)

Sponsor: Institute of Oncology Ljubljana

Updated 8 times since 2017 Last updated: Nov 9, 2020 Started: Nov 30, 2008 Primary completion: Mar 31, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01264952, this PHASE1/PHASE2 trial focuses on Liver Metastases and remains completed. Sponsored by Institute of Oncology Ljubljana, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Dec 2020 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Dec 2020 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Oncology Ljubljana
University Medical Centre Ljubljana

Data source: Institute of Oncology Ljubljana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ljubljana, Slovenia